Carlos Vila Silván on Muck Rack

Carlos Vila Silván

As seen in: La Vanguardia, Taylor & Francis Online, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Carlos Vila

Contact Carlos Vila, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

El órgano del MNAC

|
By Carlos Vila Silván
| La Vanguardia
El órgano de la sala oval del MNAC en el Palau Nacional de Montjuïc sigue mudo desde que se dejó degradar en la época franquista. He buscado información sobre posibles planes de restauración y no hay nada publicado. Se aproxima el centenario de la exposición de 1929 y de la construcción del edificio. El coste de la recuperación del órgano se ha estimado entre tres y cinco millones de euros.
Open in Who Shared Issue with article?

References: A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis

|
By Francisco Javier Carod-Artal, Carlos Vila Silván, Claudio Gasperini
| Taylor & Francis Online
[Decision of the Federal Joint Committee: an amendment to the medicines directive (AMRL): annex XII - resolutions on the benefit assessment of drugs with new ones active ingredients according to § 35a sgb v - extract from Cannabis sativa L., folium cum flore (Active ingredient combination from Delta-9-Tetrahydrocannabinol and cannabidiol) (Reassessment after the deadline). BAnz AT 30112018 B6. 2018.
Open in Who Shared Issue with article?

Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap

|
By Andrew Chan, Carlos Vila Silván
| Future Medicine
Neurodegenerative Disease ManagementAhead of Print ReviewOpen Access Abstract Effective symptomatic management of multiple sclerosis (MS) spasticity remains an unmet need for many patients. The second-line option nabiximols is the most widely investigated of the noninvasive antispasticity medications in this patient population.
Open in Who Shared Issue with article?
See all 4 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Carlos Vila

Contact Carlos Vila, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified